|
US1995A
(en)
|
|
1841-03-03 |
|
Latch of door and other locks |
|
US4946929A
(en)
|
1983-03-22 |
1990-08-07 |
Massachusetts Institute Of Technology |
Bioerodible articles useful as implants and prostheses having predictable degradation rates
|
|
US4638045A
(en)
|
1985-02-19 |
1987-01-20 |
Massachusetts Institute Of Technology |
Non-peptide polyamino acid bioerodible polymers
|
|
US4806621A
(en)
|
1986-01-21 |
1989-02-21 |
Massachusetts Institute Of Technology |
Biocompatible, bioerodible, hydrophobic, implantable polyimino carbonate article
|
|
CA1340581C
(en)
|
1986-11-20 |
1999-06-08 |
Joseph P. Vacanti |
Chimeric neomorphogenesis of organs by controlled cellular implantation using artificial matrices
|
|
US5736372A
(en)
|
1986-11-20 |
1998-04-07 |
Massachusetts Institute Of Technology |
Biodegradable synthetic polymeric fibrous matrix containing chondrocyte for in vivo production of a cartilaginous structure
|
|
US5804178A
(en)
|
1986-11-20 |
1998-09-08 |
Massachusetts Institute Of Technology |
Implantation of cell-matrix structure adjacent mesentery, omentum or peritoneum tissue
|
|
JPH01502909A
(ja)
|
1987-02-24 |
1989-10-05 |
ゾーマ・コーポレーション |
免疫毒素による人間の治療における免疫抑制
|
|
US5912017A
(en)
|
1987-05-01 |
1999-06-15 |
Massachusetts Institute Of Technology |
Multiwall polymeric microspheres
|
|
US5019379A
(en)
|
1987-07-31 |
1991-05-28 |
Massachusetts Institute Of Technology |
Unsaturated polyanhydrides
|
|
JP2670680B2
(ja)
|
1988-02-24 |
1997-10-29 |
株式会社ビーエムジー |
生理活性物質含有ポリ乳酸系微小球およびその製造法
|
|
US5010167A
(en)
|
1989-03-31 |
1991-04-23 |
Massachusetts Institute Of Technology |
Poly(amide-and imide-co-anhydride) for biological application
|
|
US5268455A
(en)
|
1989-05-25 |
1993-12-07 |
Genentech, Inc. |
Process for making biologically active polypeptides based on transforming growth factor-βsequences
|
|
US5399665A
(en)
|
1992-11-05 |
1995-03-21 |
Massachusetts Institute Of Technology |
Biodegradable polymers for cell transplantation
|
|
US5843452A
(en)
|
1992-11-09 |
1998-12-01 |
Pharmagenesis, Inc. |
Immunotherapy composition and method
|
|
US5679347A
(en)
|
1992-12-10 |
1997-10-21 |
Brigham And Women's Hospital |
Methods of isolating CD1-presented antigens, vaccines comprising CD1-presented antigens, and cell lines for use in said methods
|
|
JPH08505625A
(ja)
|
1993-01-11 |
1996-06-18 |
ダナ−ファーバー キャンサー インスティチュート |
細胞毒性ｔリンパ球応答の誘導
|
|
US5512600A
(en)
|
1993-01-15 |
1996-04-30 |
Massachusetts Institute Of Technology |
Preparation of bonded fiber structures for cell implantation
|
|
US5514378A
(en)
|
1993-02-01 |
1996-05-07 |
Massachusetts Institute Of Technology |
Biocompatible polymer membranes and methods of preparation of three dimensional membrane structures
|
|
US5543158A
(en)
|
1993-07-23 |
1996-08-06 |
Massachusetts Institute Of Technology |
Biodegradable injectable nanoparticles
|
|
US5565215A
(en)
|
1993-07-23 |
1996-10-15 |
Massachusettes Institute Of Technology |
Biodegradable injectable particles for imaging
|
|
WO1995003035A1
(en)
|
1993-07-23 |
1995-02-02 |
Massachusetts Institute Of Technology |
Polymerized liposomes with enhanced stability for oral delivery
|
|
US5468729A
(en)
|
1993-10-26 |
1995-11-21 |
Alpha 1 Biomedicals |
Method for treatment of autoimmune hepatitis
|
|
EP0759941B1
(en)
|
1994-05-18 |
2000-09-13 |
S.P.I. Synthetic Peptides Incorporated |
Heterodimer polypeptideimmunogen carrier composition and method for their use
|
|
US6007845A
(en)
|
1994-07-22 |
1999-12-28 |
Massachusetts Institute Of Technology |
Nanoparticles and microparticles of non-linear hydrophilic-hydrophobic multiblock copolymers
|
|
US5814617A
(en)
*
|
1994-10-07 |
1998-09-29 |
The United States Of America As Represented By The Secretary Of The Navy |
Protective 17 KDA malaria hepatic and erythrocytic stage immunogen and gene
|
|
JPH10507758A
(ja)
|
1994-10-19 |
1998-07-28 |
ジェネティック セラピー，インコーポレイテッド |
アデノウイルスおよび免疫抑制剤同時反復投与を伴う遺伝子治療
|
|
US5716404A
(en)
|
1994-12-16 |
1998-02-10 |
Massachusetts Institute Of Technology |
Breast tissue engineering
|
|
ATE252894T1
(de)
|
1995-01-05 |
2003-11-15 |
Univ Michigan |
Oberflächen-modifizierte nanopartikel und verfahren für ihre herstellung und verwendung
|
|
US6251957B1
(en)
|
1995-02-24 |
2001-06-26 |
Trustees Of The University Of Pennsylvania |
Method of reducing an immune response to a recombinant virus
|
|
US6123727A
(en)
|
1995-05-01 |
2000-09-26 |
Massachusetts Institute Of Technology |
Tissue engineered tendons and ligaments
|
|
JP3462313B2
(ja)
|
1995-08-24 |
2003-11-05 |
キッコーマン株式会社 |
変異型ウリカーゼ、変異型ウリカーゼ遺伝子、新規な組み換え体ｄｎａ及び変異型ウリカーゼの製造法
|
|
US6095148A
(en)
|
1995-11-03 |
2000-08-01 |
Children's Medical Center Corporation |
Neuronal stimulation using electrically conducting polymers
|
|
DE19545257A1
(de)
|
1995-11-24 |
1997-06-19 |
Schering Ag |
Verfahren zur Herstellung von morphologisch einheitlichen Mikrokapseln sowie nach diesem Verfahren hergestellte Mikrokapseln
|
|
US5902599A
(en)
|
1996-02-20 |
1999-05-11 |
Massachusetts Institute Of Technology |
Biodegradable polymer networks for use in orthopedic and dental applications
|
|
US6258823B1
(en)
|
1996-07-12 |
2001-07-10 |
Ariad Pharmaceuticals, Inc. |
Materials and method for treating or preventing pathogenic fungal infection
|
|
AU4176497A
(en)
|
1996-09-03 |
1998-03-26 |
Health Research Inc. |
Treatment of antigen presenting cells to modulate antigen presenting cell fun ction
|
|
US6060082A
(en)
|
1997-04-18 |
2000-05-09 |
Massachusetts Institute Of Technology |
Polymerized liposomes targeted to M cells and useful for oral or mucosal drug delivery
|
|
US5837752A
(en)
|
1997-07-17 |
1998-11-17 |
Massachusetts Institute Of Technology |
Semi-interpenetrating polymer networks
|
|
DK1017721T3
(da)
|
1997-09-16 |
2009-04-20 |
Univ Oregon Health & Science |
Rekombinante MHC molekyler, der kan anvendes til manipulation af antigenspecifikke T-celler
|
|
AU729589C
(en)
|
1997-10-30 |
2001-08-30 |
C.B.F. Leti, S.A. |
Tolerogenic fragments of natural allergens
|
|
US6018817A
(en)
|
1997-12-03 |
2000-01-25 |
International Business Machines Corporation |
Error correcting code retrofit method and apparatus for multiple memory configurations
|
|
US6197229B1
(en)
|
1997-12-12 |
2001-03-06 |
Massachusetts Institute Of Technology |
Method for high supercoiled DNA content microspheres
|
|
JP2001526900A
(ja)
|
1997-12-23 |
2001-12-25 |
イントロヘーネ ベスローテン フェンノートシャップ |
標的細胞の染色体ｄｎａへの外来遺伝子情報の組み込みに有用な、アデノ随伴ウイルスおよびアデノウイルスのキメラ組換えウイルス
|
|
CA2317724A1
(en)
|
1998-01-09 |
1999-07-15 |
Circassia Limited |
Methods and compositions for desensitisation
|
|
FR2775435B1
(fr)
|
1998-02-27 |
2000-05-26 |
Bioalliance Pharma |
Nanoparticules comprenant au moins un polymere et au moins un compose apte a complexer un ou plusieurs principes actifs
|
|
US6506577B1
(en)
|
1998-03-19 |
2003-01-14 |
The Regents Of The University Of California |
Synthesis and crosslinking of catechol containing copolypeptides
|
|
US6632922B1
(en)
|
1998-03-19 |
2003-10-14 |
The Regents Of The University Of California |
Methods and compositions for controlled polypeptide synthesis
|
|
US6686446B2
(en)
|
1998-03-19 |
2004-02-03 |
The Regents Of The University Of California |
Methods and compositions for controlled polypeptide synthesis
|
|
SE9801288D0
(sv)
|
1998-04-14 |
1998-04-14 |
Astra Ab |
Vaccine delivery system and metod of production
|
|
US6436392B1
(en)
|
1998-05-20 |
2002-08-20 |
University Of Iowa Research Foundation |
Adeno-associated virus vectors
|
|
EP1100542B1
(en)
|
1998-08-06 |
2005-06-22 |
Mountain View Pharmaceuticals, Inc. |
Peg-urate oxidase conjugates and use thereof
|
|
US6306640B1
(en)
|
1998-10-05 |
2001-10-23 |
Genzyme Corporation |
Melanoma antigenic peptides
|
|
CA2345817C
(en)
|
1998-10-05 |
2013-02-12 |
M&E Biotech A/S |
Novel methods for therapeutic vaccination
|
|
HK1042114B
(zh)
|
1998-10-23 |
2006-09-29 |
Amgen K-A, Inc. |
与mp1受体结合并具有血小板生成活性的模拟二聚体血小板生成素肽
|
|
US6759237B1
(en)
|
1998-11-05 |
2004-07-06 |
The Trustees Of The University Of Pennsylvania |
Adeno-associated virus serotype 1 nucleic acid sequences, vectors and host cells containing same
|
|
US20040009535A1
(en)
|
1998-11-27 |
2004-01-15 |
Celltech R&D, Inc. |
Compositions and methods for increasing bone mineralization
|
|
JP4813660B2
(ja)
|
1998-11-27 |
2011-11-09 |
ダーウィン ディスカバリー リミテッド |
骨鉱化作用を増加するための組成物および方法
|
|
US6153217A
(en)
*
|
1999-01-22 |
2000-11-28 |
Biodelivery Sciences, Inc. |
Nanocochleate formulations, process of preparation and method of delivery of pharmaceutical agents
|
|
US6800296B1
(en)
|
1999-05-19 |
2004-10-05 |
Massachusetts Institute Of Technology |
Modification of surfaces using biological recognition events
|
|
AU5470900A
(en)
|
1999-06-08 |
2000-12-28 |
Children's Hospital Of Philadelphia, The |
Methods for preventing formation of inhibitory antibodies in the setting of genetherapy
|
|
DE19951970A1
(de)
|
1999-10-28 |
2001-05-03 |
Bionetworks Gmbh |
Arzneimittel für die Toleranzinduktion
|
|
EP1267946A4
(en)
|
2000-02-28 |
2008-07-02 |
Genesegues Inc |
SYSTEM AND METHOD FOR ENCAPSULATING NANOCAPSULES
|
|
WO2001068133A1
(en)
|
2000-03-14 |
2001-09-20 |
Genetics Institute, Inc. |
Use of rapamycin and agents that inhibit b7 activity in immunomodulation
|
|
WO2001085208A2
(en)
|
2000-05-05 |
2001-11-15 |
Cytos Biotechnology Ag |
Molecular antigen arrays and vaccines
|
|
AU2001265187A1
(en)
|
2000-05-30 |
2001-12-11 |
Baylor College Of Medicine |
Chimeric viral vectors for gene therapy
|
|
ATE318923T1
(de)
|
2000-06-01 |
2006-03-15 |
Univ North Carolina |
Doppelsträngige parvovirus-vektoren
|
|
US20040204379A1
(en)
|
2000-06-19 |
2004-10-14 |
Cheng Seng H. |
Combination enzyme replacement, gene therapy and small molecule therapy for lysosomal storage diseases
|
|
AU2001269923A1
(en)
|
2000-06-19 |
2002-01-02 |
Genzyme Corporation |
Combination enzyme replacement, gene therapy and small molecule therapy for lysosomal storage diseases
|
|
US20020014242A1
(en)
|
2000-07-31 |
2002-02-07 |
Abraham Scaria |
Use of rapamycin to inhibit immune response and induce tolerance to gene therapy vector and encoded transgene products
|
|
MY138883A
(en)
*
|
2000-08-29 |
2009-08-28 |
Government Of Malaysia As Represented By The Ministry Of Science Tehnology And Innovation Malaysia |
Use of asiatic acid for treatment of cencer
|
|
CA2319928A1
(en)
|
2000-09-18 |
2002-03-18 |
Vasogen Ireland Limited |
Apoptosis-mimicking synthetic entities and use thereof in medical treatments
|
|
GB0025414D0
(en)
|
2000-10-16 |
2000-11-29 |
Consejo Superior Investigacion |
Nanoparticles
|
|
WO2002088304A2
(en)
|
2001-04-11 |
2002-11-07 |
Trustees Of The University Of Pennsylvania |
Compositions and methods for suppressing immune responses
|
|
US6913915B2
(en)
|
2001-08-02 |
2005-07-05 |
Phoenix Pharmacologics, Inc. |
PEG-modified uricase
|
|
WO2003020797A1
(en)
|
2001-08-30 |
2003-03-13 |
The Regents Of The University Of California |
Transition metal initiators for controlled poly (beta-peptide) synthesis from beta-lactam monomers
|
|
CN1294268C
(zh)
|
2001-09-03 |
2007-01-10 |
上海三维生物技术有限公司 |
可在肿瘤细胞内特异性复制并扩散的重组腺病毒载体
|
|
WO2003033526A2
(en)
|
2001-10-19 |
2003-04-24 |
Isotechnika Inc. |
Synthesis of cyclosporin analogs
|
|
ES2975413T3
(es)
|
2001-12-17 |
2024-07-05 |
Univ Pennsylvania |
Secuencias de serotipo 8 de virus adenoasociado (AAV), vectores que las contienen y usos de las mismas
|
|
GB0207440D0
(en)
|
2002-03-28 |
2002-05-08 |
Ppl Therapeutics Scotland Ltd |
Tolerogenic antigen-presenting cells
|
|
US20040038303A1
(en)
|
2002-04-08 |
2004-02-26 |
Unger Gretchen M. |
Biologic modulations with nanoparticles
|
|
US7485314B2
(en)
|
2002-05-06 |
2009-02-03 |
Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center |
Induction of antigen specific immunologic tolerance
|
|
CA2486621A1
(en)
|
2002-05-22 |
2003-12-04 |
The Cleveland Clinic Foundation |
Induction and maintenance of tolerance to composite tissue allografts
|
|
WO2003102162A2
(en)
|
2002-06-04 |
2003-12-11 |
University Of Pittsburgh Of The Commonwealth System Of Higher Education |
Novel tolerogenic dendritic cells and therapeutic uses therefor
|
|
JP2005532067A
(ja)
|
2002-07-03 |
2005-10-27 |
コーリー ファーマシューティカル グループ，インコーポレイテッド |
刺激性免疫応答用の核酸組成物
|
|
US9809654B2
(en)
|
2002-09-27 |
2017-11-07 |
Vaccinex, Inc. |
Targeted CD1d molecules
|
|
ES2312820T3
(es)
|
2002-11-29 |
2009-03-01 |
Maria Grazia Roncarolo |
Paramicina e il-10 para el tratamiento de enfermedades autoinmunes.
|
|
WO2004071493A1
(en)
|
2003-02-17 |
2004-08-26 |
Peter Burkhard |
Peptidic nanoparticles as drug delivery and antigen display systems
|
|
WO2004075861A2
(en)
|
2003-02-26 |
2004-09-10 |
Children's Hospital, Inc. |
Recombinant adeno-associated virus production
|
|
DE602004025332D1
(de)
|
2003-03-14 |
2010-03-18 |
Wyeth Corp |
Antikörper gegen il21-rezeptor und deren verwendung
|
|
RU2351362C2
(ru)
|
2003-03-26 |
2009-04-10 |
Цитос Байотекнолоджи Аг |
КОНЪЮГАТЫ ПЕПТИДА Melan-A, АНАЛОГА ВИРУСОПОДОБНОЙ ЧАСТИЦЫ
|
|
US7186699B2
(en)
|
2003-06-03 |
2007-03-06 |
Cell Genesys, Inc. |
Method for treating cancer by vector-mediated delivery of one or more anti-angiogenic or pro-apoptotic genes
|
|
US7727969B2
(en)
|
2003-06-06 |
2010-06-01 |
Massachusetts Institute Of Technology |
Controlled release nanoparticle having bound oligonucleotide for targeted delivery
|
|
EP1486567A1
(en)
|
2003-06-11 |
2004-12-15 |
Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts |
Improved adeno-associated virus (AAV) vector for gene therapy
|
|
US7381409B2
(en)
|
2003-06-16 |
2008-06-03 |
Celltech R&D, Inc. |
Antibodies specific for sclerostin and methods of screening and use therefor
|
|
US20060251711A1
(en)
|
2003-08-28 |
2006-11-09 |
Vgsk Technologies, Inc. |
Sterically stabilized carrier for aerosol therapeutics, compositions and methods for treating diseases of the respiratory tract of a mammal
|
|
DE10347710B4
(de)
|
2003-10-14 |
2006-03-30 |
Johannes-Gutenberg-Universität Mainz |
Rekombinante Impfstoffe und deren Verwendung
|
|
US20080160089A1
(en)
|
2003-10-14 |
2008-07-03 |
Medivas, Llc |
Vaccine delivery compositions and methods of use
|
|
AU2004311630A1
(en)
|
2003-12-02 |
2005-07-21 |
Cytimmune Sciences, Inc. |
Methods and compositions for the production of monoclonal antibodies
|
|
US8263129B2
(en)
|
2003-12-19 |
2012-09-11 |
The University Of North Carolina At Chapel Hill |
Methods for fabricating isolated micro-and nano-structures using soft or imprint lithography
|
|
WO2005097116A1
(en)
|
2004-04-08 |
2005-10-20 |
Applied Research Systems Ars Holding N.V. |
Composition comprising a jnk inhibitor and cyclosporin
|
|
CA2566506A1
(en)
|
2004-06-01 |
2005-12-15 |
Innogenetics N.V. |
Peptides for inducing a ctl and/or htl response to hepatitis c virus
|
|
AU2005326322B2
(en)
|
2004-07-01 |
2009-02-05 |
Yale University |
Targeted and high density drug loaded polymeric materials
|
|
US20080206270A1
(en)
|
2004-07-08 |
2008-08-28 |
Minev Boris R |
Enhancing Class I Antigen Presentation With Synthetic Sequences
|
|
FR2874384B1
(fr)
|
2004-08-17 |
2010-07-30 |
Genethon |
Vecteur viral adeno-associe pour realiser du saut d'exons dans un gene codant une proteine a domaines dispensables
|
|
JP2008515806A
(ja)
|
2004-10-05 |
2008-05-15 |
タノックス インコーポレイテッド |
代償療法を受けている患者における過敏症および／またはアナフィラキシーの抗ＩｇＥ抗体による処置および予防
|
|
US9492400B2
(en)
|
2004-11-04 |
2016-11-15 |
Massachusetts Institute Of Technology |
Coated controlled release polymer particles as efficient oral delivery vehicles for biopharmaceuticals
|
|
CA2590675A1
(en)
|
2004-12-15 |
2006-06-22 |
Elan Pharma International Ltd. |
Nanoparticulate tacrolimus formulations
|
|
WO2006069419A1
(en)
|
2004-12-31 |
2006-07-06 |
Iceutica Pty Ltd |
Nanoparticle composition and methods for synthesis thereof
|
|
GB0504206D0
(en)
|
2005-03-01 |
2005-04-06 |
Glaxo Group Ltd |
Combination therapy
|
|
JP2008532953A
(ja)
|
2005-03-08 |
2008-08-21 |
ライフサイクル ファーマ エー／エス |
シロリムスおよび／またはその類縁物質を含む医薬組成物
|
|
AU2006227623B2
(en)
|
2005-03-17 |
2011-10-20 |
Elan Pharma International Limited |
Injectable compositions of nanoparticulate immunosuppressive compounds
|
|
US7884109B2
(en)
|
2005-04-05 |
2011-02-08 |
Wyeth Llc |
Purine and imidazopyridine derivatives for immunosuppression
|
|
EP1871343A2
(en)
|
2005-04-12 |
2008-01-02 |
Wisconsin Alumni Research Foundation |
Micelle composition of polymer and passenger drug
|
|
WO2006122223A2
(en)
|
2005-05-10 |
2006-11-16 |
Emory University |
Strategies for delivery of active agents using micelles and particles
|
|
MX2007016039A
(es)
|
2005-06-17 |
2008-10-27 |
Univ North Carolina |
Metodos, sistemas y materiales de fabricacion de nanoparticulas.
|
|
TW200711649A
(en)
|
2005-06-17 |
2007-04-01 |
Combinatorx Inc |
Combination therapy for the treatment of immunoinflammatory disorders
|
|
KR20080047395A
(ko)
|
2005-08-25 |
2008-05-28 |
다이호야쿠힌고교 가부시키가이샤 |
Ｔ세포 인식 에피토프 펩티드를 고정화 또는 내포화한생분해성 나노입자
|
|
CN1979166A
(zh)
*
|
2005-11-30 |
2007-06-13 |
北京有色金属研究总院 |
一种制备免疫检测用纳米胶体金的工艺方法及其反应装置
|
|
EP2345412A1
(en)
|
2005-12-02 |
2011-07-20 |
The Johns Hopkins University |
Use of high-dose oxazaphosphorine drugs for treating immune disorders
|
|
US20070128289A1
(en)
*
|
2005-12-07 |
2007-06-07 |
Zhao Jonathon Z |
Nano-and/or micro-particulate formulations for local injection-based treatment of vascular diseases
|
|
JP2009521409A
(ja)
|
2005-12-08 |
2009-06-04 |
ユニバーシティー オブ ルーイビル リサーチ ファンデーション，インコーポレーテッド |
制御性ｔ細胞を増殖する方法と組成物
|
|
WO2007070682A2
(en)
|
2005-12-15 |
2007-06-21 |
Massachusetts Institute Of Technology |
System for screening particles
|
|
WO2007087341A2
(en)
|
2006-01-25 |
2007-08-02 |
The Board Of Trustees Of The University Of Illinois |
Tolerogenic biodegradable artificial antigen presenting system
|
|
AU2007215328A1
(en)
|
2006-02-13 |
2007-08-23 |
Oncolytics Biotech Inc. |
Use of local immune suppression to enhance oncolytic viral therapy
|
|
US8021689B2
(en)
|
2006-02-21 |
2011-09-20 |
Ecole Polytechnique Federale de Lausanne (“EPFL”) |
Nanoparticles for immunotherapy
|
|
US8568487B2
(en)
|
2006-02-27 |
2013-10-29 |
Biomet Manufacturing, Llc |
Patient-specific hip joint devices
|
|
EP2004666B1
(en)
|
2006-03-27 |
2014-09-03 |
Globeimmune, Inc. |
Ras mutation and compositions and methods related thereto
|
|
AU2007243282A1
(en)
|
2006-04-28 |
2007-11-08 |
Resolvyx Pharmaceuticals, Inc. |
Compositions and methods for the treatment of cardiovascular disease
|
|
EP2019691B1
(en)
|
2006-05-15 |
2020-08-12 |
Massachusetts Institute of Technology |
Polymers for functional particles
|
|
WO2007137117A2
(en)
|
2006-05-17 |
2007-11-29 |
Massachusetts Institute Of Technology |
Aptamer-directed drug delivery
|
|
EP1880729A1
(en)
|
2006-07-20 |
2008-01-23 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Use of soluble CD160 to suppress immunity
|
|
CN101484461B
(zh)
*
|
2006-08-18 |
2014-09-17 |
阿哥斯医疗公司 |
Cd83在联合治疗中的用途
|
|
WO2008036374A2
(en)
|
2006-09-21 |
2008-03-27 |
Medistem Laboratories, Inc. |
Allogeneic stem cell transplants in non-conditioned recipients
|
|
CA2665343C
(en)
|
2006-10-05 |
2014-12-16 |
The Johns Hopkins University |
Water-dispersible oral, parenteral, and topical formulations for poorly water soluble drugs using smart polymeric nanoparticles
|
|
CA2702340C
(en)
|
2006-10-12 |
2014-12-16 |
The University Of Queensland |
Compositions and methods for modulating immune responses
|
|
CN101646418B
(zh)
*
|
2006-10-12 |
2013-07-17 |
昆士兰大学 |
调节免疫应答的组合物和方法
|
|
US20100112077A1
(en)
*
|
2006-11-06 |
2010-05-06 |
Abraxis Bioscience, Llc |
Nanoparticles of paclitaxel and albumin in combination with bevacizumab against cancer
|
|
US20100172994A1
(en)
|
2006-11-22 |
2010-07-08 |
University Of Florida Research Foundation, Inc. |
Nanoparticles for Protection of Cells from Oxidative Stress
|
|
WO2008069942A2
(en)
|
2006-12-05 |
2008-06-12 |
Biogen Idec Ma Inc. |
Novel methods of enhancing delivery of a gene therapy vector using steroids
|
|
ES2533566T3
(es)
|
2006-12-29 |
2015-04-13 |
The Regents Of The University Of Colorado, A Body Corporate |
Diana diagnóstica y terapéutica para enfermedades autoinmunitarias y sus usos
|
|
JP5357782B2
(ja)
|
2007-02-21 |
2013-12-04 |
バクシネックス インコーポレーティッド |
抗原負荷ＣＤ１ｄ分子によるＮＫＴ細胞活性の調節
|
|
KR20080078204A
(ko)
|
2007-02-22 |
2008-08-27 |
크레아젠 주식회사 |
면역억제능이 증가된 간엽줄기세포-매개 자가유래수지상세포
|
|
LT2481402T
(lt)
|
2007-03-07 |
2018-10-25 |
Abraxis Bioscience, Llc |
Nanodalelė, apimanti rapamiciną ir albuminą, kaip priešvėžinį agentą
|
|
AU2008222678B2
(en)
|
2007-03-07 |
2013-01-17 |
The General Hospital Corporation |
Compositions and methods for the prevention and treatment of autoimmune conditions
|
|
CN101730526A
(zh)
*
|
2007-03-07 |
2010-06-09 |
阿布拉科斯生物科学有限公司 |
作为抗癌剂的包含雷帕霉素和白蛋白的纳米颗粒
|
|
EP2061440A2
(en)
|
2007-04-04 |
2009-05-27 |
Sigmoid Pharma Limited |
A pharmaceutical composition of tacrolimus
|
|
WO2008124632A1
(en)
*
|
2007-04-04 |
2008-10-16 |
Massachusetts Institute Of Technology |
Amphiphilic compound assisted nanoparticles for targeted delivery
|
|
CA2683063A1
(en)
|
2007-04-09 |
2008-10-16 |
Chimeros, Inc. |
Self-assembling nanoparticle drug delivery system
|
|
AU2008239795A1
(en)
|
2007-04-12 |
2008-10-23 |
Emory University |
Novel strategies for delivery of active agents using micelles and particles
|
|
WO2008150868A1
(en)
|
2007-05-29 |
2008-12-11 |
The Board Of Trustees Of The University Of Illinois |
Methods for inducing therapeutic t cells for immune diseases
|
|
US20080311140A1
(en)
|
2007-05-29 |
2008-12-18 |
Baylor College Of Medicine |
Antigen specific immunosuppression by dendritic cell therapy
|
|
JP6035503B2
(ja)
|
2007-05-31 |
2016-11-30 |
アカデミシュ ジーケンハウス ライデン ハー．オー．デー．エン． ルムク |
ワクチンで使用するための、子宮頸部悪性腫瘍に浸潤するｔ細胞によって標的とされるｈｐｖエピトープ
|
|
AU2008258646A1
(en)
|
2007-06-05 |
2008-12-11 |
Fondazione Centro San Raffaele Del Monte Tabor |
Induction of tolerogenic phenotype in mature dendritic cells
|
|
US20090004259A1
(en)
|
2007-06-14 |
2009-01-01 |
Consejo Nacional De Investigaciones Cientificas Y Tecnicas (Conicet) |
Methods of preparing a therapeutic formulation comprising galectin-induced tolerogenic dendritic cells
|
|
US8138183B2
(en)
|
2007-07-09 |
2012-03-20 |
Astrazeneca Ab |
Morpholino pyrimidine derivatives used in diseases linked to mTOR kinase and/or PI3K
|
|
GB0714963D0
(en)
|
2007-08-01 |
2007-09-12 |
Novartis Ag |
Compositions comprising antigens
|
|
EA023303B1
(ru)
|
2007-08-15 |
2016-05-31 |
Сиркейшиа Лимитед |
Пептидная композиция для формирования толерантности к клещам домашней пыли и ее применение
|
|
JP2011520769A
(ja)
*
|
2007-09-21 |
2011-07-21 |
サイトイミューン サイエンシズ インコーポレイテッド |
ナノ治療コロイド金属組成物および方法
|
|
CA2917512C
(en)
|
2007-10-12 |
2025-08-05 |
President And Fellows Of Harvard College |
VACCINE NANOTECHNOLOGY
|
|
WO2009062502A1
(en)
|
2007-11-13 |
2009-05-22 |
Dandrit Biotech A/S |
Method for generating tolerogenic dendritic cells employing decreased temperature
|
|
US20090142318A1
(en)
*
|
2007-11-30 |
2009-06-04 |
Therakos, Inc. |
METHOD TO EXPAND nTREG CELLS USING p70 S6 KINASE ANTAGONIST
|
|
AU2008346801A1
(en)
|
2007-12-31 |
2009-07-16 |
Nanocor Therapeutics, Inc. |
RNA interference for the treatment of heart failure
|
|
JP5474831B2
(ja)
|
2008-02-08 |
2014-04-16 |
テルモ株式会社 |
生理活性物質管腔内制御送達用薬剤送達装置およびその作成方法
|
|
EP2262489A2
(en)
|
2008-02-28 |
2010-12-22 |
Deutsches Krebsforschungszentrum, Stiftung des öffentlichen Rechts |
Hollow nanoparticles and uses thereof
|
|
WO2009131712A2
(en)
|
2008-04-25 |
2009-10-29 |
Duke University Medical Center |
Regulatory b cells and their uses
|
|
US8815817B2
(en)
|
2008-05-15 |
2014-08-26 |
Dynavax Technologies Corporation |
Long term disease modification using immunostimulatory oligonucleotides
|
|
WO2009145238A1
(ja)
|
2008-05-27 |
2009-12-03 |
国立大学法人名古屋大学 |
免疫調節剤及びその利用
|
|
US20090297621A1
(en)
|
2008-06-03 |
2009-12-03 |
Abbott Cardiovascular Systems Inc. |
Microparticles For The Treatment Of Disease
|
|
WO2010005726A2
(en)
|
2008-06-16 |
2010-01-14 |
Bind Biosciences Inc. |
Therapeutic polymeric nanoparticles with mtor inhibitors and methods of making and using same
|
|
EA020954B1
(ru)
|
2008-06-16 |
2015-03-31 |
Бинд Терапьютикс, Инк. |
Загруженные лекарственным средством полимерные наночастицы, фармацевтическая композиция и способ лечения рака
|
|
US20120034155A1
(en)
|
2010-08-03 |
2012-02-09 |
Searete Llc, A Limited Liability Corporation Of The State Of Delaware |
Artificial cells
|
|
EP2331124A1
(en)
|
2008-08-15 |
2011-06-15 |
Circassia Limited |
T-cell antigen peptide from allergen for stimulation of il-10 production
|
|
US8323696B2
(en)
|
2008-08-29 |
2012-12-04 |
Ecole Polytechnique Federale De Lausanne |
Nanoparticles for immunotherapy
|
|
WO2010027471A2
(en)
|
2008-09-04 |
2010-03-11 |
The General Hospital Corporation |
Hydrogels for vocal cord and soft tissue augmentation and repair
|
|
CN101676291B
(zh)
|
2008-09-18 |
2012-05-09 |
上海海和药物研究开发有限公司 |
一类雷帕霉素碳酸酯类似物、其药物组合物及其制备方法和用途
|
|
US8889124B2
(en)
|
2008-09-25 |
2014-11-18 |
The Board Of Trustees Of The Leland Stanford Junior University |
Tolerogenic populations of dendritic cells
|
|
WO2010037402A1
(en)
|
2008-10-02 |
2010-04-08 |
Dako Denmark A/S |
Molecular vaccines for infectious disease
|
|
US8277812B2
(en)
|
2008-10-12 |
2012-10-02 |
Massachusetts Institute Of Technology |
Immunonanotherapeutics that provide IgG humoral response without T-cell antigen
|
|
US8343497B2
(en)
|
2008-10-12 |
2013-01-01 |
The Brigham And Women's Hospital, Inc. |
Targeting of antigen presenting cells with immunonanotherapeutics
|
|
US8343498B2
(en)
*
|
2008-10-12 |
2013-01-01 |
Massachusetts Institute Of Technology |
Adjuvant incorporation in immunonanotherapeutics
|
|
US8591905B2
(en)
|
2008-10-12 |
2013-11-26 |
The Brigham And Women's Hospital, Inc. |
Nicotine immunonanotherapeutics
|
|
JP5552630B2
(ja)
|
2008-10-24 |
2014-07-16 |
学校法人 聖マリアンナ医科大学 |
Ｈｔｌｖ−ｉ関連脊髄症を治療または予防するための医薬、およびｈｔｌｖ−ｉ関連脊髄症の患者に対する抗体療法の効果を試験する方法
|
|
US20120015899A1
(en)
|
2008-10-25 |
2012-01-19 |
Plant Bioscience, Limited |
Modified plant virus particles and uses therefor
|
|
WO2010056143A1
(en)
|
2008-11-13 |
2010-05-20 |
Instituto De Medicina Molecular |
The use of adjuvant to facilitate the induction of immune tolerance
|
|
EP2379064B1
(en)
|
2008-12-15 |
2020-02-26 |
Pfizer Inc. |
Long circulating nanoparticles for sustained release of therapeutic agents
|
|
MX2011007559A
(es)
|
2009-01-20 |
2011-12-06 |
Myelin Repair Foundation Inc |
Composiciones y metodos para induccion de tolerancia antigeno-especifica.
|
|
EP2620447B1
(en)
|
2009-02-04 |
2015-09-09 |
Universität Leipzig |
Vector(s) containing an inducible gene encoding a CDK4/CDK6 inhibitor useful for treating neurodegenerative disorders
|
|
ES2532759T3
(es)
|
2009-02-05 |
2015-03-31 |
Circassia Limited |
Péptidos de plantas herbáceas para vacunas
|
|
KR20100099849A
(ko)
|
2009-03-04 |
2010-09-15 |
동국대학교 산학협력단 |
면역억제제와 트랜스글루타미나제 2의 억제제를 함유한 아토피 피부염 치료용 조성물
|
|
US8679837B2
(en)
|
2009-04-02 |
2014-03-25 |
University Of Florida Research Foundation, Inc. |
Inducible system for highly efficient production of recombinant Adeno-associated virus (rAAV) vectors
|
|
GB0906159D0
(en)
|
2009-04-09 |
2009-05-20 |
Summit Corp Plc |
Drug combination for the treatment of proteostatic diseases
|
|
KR20120022984A
(ko)
|
2009-04-21 |
2012-03-12 |
셀렉타 바이오사이언시즈, 인크. |
Ｔｈ１ 편향 반응을 제공하는 면역나노치료법
|
|
WO2010123501A1
(en)
|
2009-04-22 |
2010-10-28 |
Massachusetts Institute Of Technology |
Innate immune suppression enables repeated delivery of long rna molecules
|
|
EP3461840A1
(en)
|
2009-04-27 |
2019-04-03 |
Immuron Limited |
Anti-lps enriched immunoglobulin preparation for use in treatment and/or prophylaxis of non alcoholic steatohepatitis
|
|
WO2010138192A2
(en)
|
2009-05-27 |
2010-12-02 |
Selecta Biosciences, Inc. |
Nanocarriers possessing components with different rates of release
|
|
RU2535038C2
(ru)
|
2009-06-25 |
2014-12-10 |
Криэлта Фармасьютикалз ЭлЭлСи |
Способы и наборы для прогнозирования риска инфузионных реакций и опосредованной антителами потери ответа при терапии пэгилированной уриказой с помощью мониторинга содержания мочевой кислоты в сыворотке крови
|
|
EA023897B1
(ru)
|
2009-08-26 |
2016-07-29 |
Селекта Байосайенсиз, Инк. |
Композиции, которые индуцируют хелперное действие т-клеток
|
|
AR078161A1
(es)
|
2009-09-11 |
2011-10-19 |
Hoffmann La Roche |
Formulaciones farmaceuticas muy concentradas de un anticuerpo anti cd20. uso de la formulacion. metodo de tratamiento.
|
|
EP2305277A1
(en)
|
2009-09-18 |
2011-04-06 |
Forskarpatent I Syd AB |
Use of tolerogenic dendritic cells in treatment and prevention of atherosclerosis
|
|
CN101703781A
(zh)
|
2009-10-28 |
2010-05-12 |
陕西北美基因股份有限公司 |
一种免疫抑制剂的磁性载药方法
|
|
KR101267813B1
(ko)
*
|
2009-12-30 |
2013-06-04 |
주식회사 삼양바이오팜 |
향상된 수용해도를 갖는 라파마이신 함유 고분자나노입자 주사제형 조성물 및 그 제조방법, 및 방사선 요법과 병용하기 위한 항암 조성물
|
|
US20110171248A1
(en)
|
2010-01-08 |
2011-07-14 |
Selecta Biosciences, Inc. |
Synthetic virus-like particles conjugated to human papillomavirus capsid peptides for use as vaccines
|
|
WO2011097511A1
(en)
|
2010-02-05 |
2011-08-11 |
The United States Of America, As Represented By The Secretary Department Of Health & Human Services |
REGULATORY B CELLS (tBREGS) AND THEIR USE
|
|
JP2013521002A
(ja)
|
2010-03-05 |
2013-06-10 |
プレジデント アンド フェロウズ オブ ハーバード カレッジ |
誘導樹状細胞組成物及びその使用
|
|
US20110272836A1
(en)
|
2010-04-12 |
2011-11-10 |
Selecta Biosciences, Inc. |
Eccentric vessels
|
|
US20110262491A1
(en)
|
2010-04-12 |
2011-10-27 |
Selecta Biosciences, Inc. |
Emulsions and methods of making nanocarriers
|
|
US8927514B2
(en)
|
2010-04-30 |
2015-01-06 |
City Of Hope |
Recombinant adeno-associated vectors for targeted treatment
|
|
WO2011140522A1
(en)
|
2010-05-07 |
2011-11-10 |
Xoma Technology Ltd. |
METHODS FOR THE TREATMENT OF IL-1β RELATED CONDITIONS
|
|
CN102905728B
(zh)
|
2010-05-26 |
2015-11-25 |
西莱克塔生物科技公司 |
具有不偶合的佐剂的纳米载体组合物
|
|
MY166014A
(en)
|
2010-06-07 |
2018-05-21 |
Abraxis Bioscience Llc |
Combination therapy methods for treating proliferative diseases
|
|
US10131875B2
(en)
|
2010-08-04 |
2018-11-20 |
Duke University |
Regulatory B cells and their uses
|
|
JP6017422B2
(ja)
|
2010-08-10 |
2016-11-02 |
エコール・ポリテクニーク・フェデラル・ドゥ・ローザンヌ（ウペエフエル）Ｅｃｏｌｅ Ｐｏｌｙｔｅｃｈｎｉｑｕｅ Ｆｅｄｅｒａｌｅ ｄｅ Ｌａｕｓａｎｎｅ （ＥＰＦＬ） |
赤血球結合療法
|
|
US20120058153A1
(en)
|
2010-08-20 |
2012-03-08 |
Selecta Biosciences, Inc. |
Synthetic nanocarrier vaccines comprising proteins obtained or derived from human influenza a virus hemagglutinin
|
|
MX2013002173A
(es)
*
|
2010-08-23 |
2013-05-06 |
Selecta Biosciences Inc |
Formas farmaceuticas dirigidas de epitopos multiples para la induccion de una respuesta inmunologica frente a antigenos.
|
|
CA2810842C
(en)
|
2010-09-09 |
2018-06-26 |
Micell Technologies, Inc. |
Macrolide dosage forms
|
|
AU2011316777A1
(en)
|
2010-10-22 |
2013-06-13 |
University Of Florida Research Foundation, Inc. |
Antigen-specific, tolerance-inducing microparticles and uses thereof
|
|
EP2640190A4
(en)
|
2010-11-05 |
2016-05-11 |
Selecta Biosciences Inc |
MODIFIED NICOTINIC COMPOUNDS AND ASSOCIATED METHODS
|
|
WO2012092552A1
(en)
|
2010-12-30 |
2012-07-05 |
Selecta Biosciences, Inc. |
Synthetic nanocarriers with reactive groups that release biologically active agents
|
|
CA2826836A1
(en)
|
2011-02-08 |
2012-08-16 |
The Charlotte-Mecklenburg Hospital Authority D/B/A Carolinas Medical Center |
Antisense oligonucleotides
|
|
US10392632B2
(en)
|
2011-02-14 |
2019-08-27 |
The Children's Hospital Of Philadelphia |
AAV8 vector with enhanced functional activity and methods of use thereof
|
|
US8654487B2
(en)
|
2011-03-11 |
2014-02-18 |
Siemens Industry, Inc. |
Methods, systems, and apparatus and for detecting parallel electrical arc faults
|
|
EP2694040A4
(en)
|
2011-03-25 |
2014-09-03 |
Selecta Biosciences Inc |
SYNTHETIC NANOTRACKERS WITH OSMOTICALLY MEDIATED RELEASE
|
|
JP2014511687A
(ja)
|
2011-03-31 |
2014-05-19 |
モデルナ セラピューティクス インコーポレイテッド |
工学操作された核酸の送達および製剤
|
|
WO2012145509A2
(en)
|
2011-04-19 |
2012-10-26 |
The Research Foundation Of State University Of New York |
Adeno-associated-virus rep sequences, vectors, and viruses
|
|
EP2699688A1
(en)
|
2011-04-20 |
2014-02-26 |
The Trustees Of The University Of Pennsylvania |
Regimens and compositions for aav-mediated passive immunization of airborne pathogens
|
|
KR20140041505A
(ko)
*
|
2011-04-29 |
2014-04-04 |
셀렉타 바이오사이언시즈, 인크. |
조절 b 세포 유도를 위한 관용원성 합성 나노운반체
|
|
MX2013013445A
(es)
|
2011-05-16 |
2014-07-28 |
Genzyme Corp |
Induccion de tolerancia inmunologica utilizando metotrexato.
|
|
US20130028857A1
(en)
|
2011-07-29 |
2013-01-31 |
Selecta Biosciences, Inc. |
Synthetic nanocarriers comprising polymers comprising multiple immunomodulatory agents
|
|
WO2013036296A1
(en)
|
2011-09-06 |
2013-03-14 |
Selecta Biosciences, Inc. |
Compositions and methods for producing antigen-specific induced tolerogenic dendritic cells with synthetic nanocarriers
|
|
AU2012304313A1
(en)
|
2011-09-08 |
2014-03-06 |
University Of Florida Research Foundation, Inc. |
Materials and methods for modulating immune responses
|
|
US8865487B2
(en)
|
2011-09-20 |
2014-10-21 |
General Electric Company |
Large area hermetic encapsulation of an optoelectronic device using vacuum lamination
|
|
EP2763701B1
(en)
|
2011-10-03 |
2018-12-19 |
Moderna Therapeutics, Inc. |
Modified nucleosides, nucleotides, and nucleic acids, and uses thereof
|
|
WO2013058812A1
(en)
|
2011-10-19 |
2013-04-25 |
President And Fellows Of Harvard College |
Targeted delivery to pancreatic islet endothelial cells
|
|
EP2591801A1
(en)
|
2011-11-14 |
2013-05-15 |
Universitätsklinikum Hamburg-Eppendorf |
Nanoparticle compositions for generation of regulatory T cells and treatment of autoimmune diseases and other chronic inflammatory conditions
|
|
CA2856137A1
(en)
|
2011-11-22 |
2013-05-30 |
The Children's Hospital Of Philadelphia |
Virus vectors for highly efficient transgene delivery
|
|
KR102057540B1
(ko)
|
2012-02-17 |
2019-12-19 |
더 칠드런스 호스피탈 오브 필라델피아 |
세포, 기관 및 조직으로의 유전자 전이를 위한 ａａｖ 벡터 조성물 및 방법
|
|
JP6342886B2
(ja)
|
2012-04-18 |
2018-06-13 |
ザ・チルドレンズ・ホスピタル・オブ・フィラデルフィアＴｈｅ Ｃｈｉｌｄｒｅｎ’Ｓ Ｈｏｓｐｉｔａｌ Ｏｆ Ｐｈｉｌａｄｅｌｐｈｉａ |
Ａａｖカプシドバリアントを使用した高効率な遺伝子導入のための組成物及び方法
|
|
WO2013163337A1
(en)
|
2012-04-24 |
2013-10-31 |
The Ohio State University |
Compositions and methods for treating and preventing porcine reproductive and respiratory syndrome
|
|
AU2013315125B2
(en)
|
2012-09-17 |
2018-07-26 |
Pfizer Inc. |
Therapeutic nanoparticles comprising a therapeutic agent and methods of making and using same
|
|
CN102871966B
(zh)
|
2012-10-19 |
2013-11-20 |
东南大学 |
用于改善雷帕霉素生物利用度的纳米载药颗粒及其制备方法
|
|
US20160038575A1
(en)
|
2013-03-15 |
2016-02-11 |
Haplomics, Inc. |
Compositions and methods for immune tolerance induction to factor viii replacement therapies in subjects with hemophilia a
|
|
US9944918B2
(en)
|
2013-03-15 |
2018-04-17 |
The United States Of America, As Represented By The Secretary, Dept. Of Health & Human Services |
Synthetic methylmalonyl-CoA mutase transgene for the treatment of MUT class methylmalonic acidemia (MMA)
|
|
US9828587B2
(en)
|
2013-04-08 |
2017-11-28 |
University Of Iowa Research Foundation |
Chimeric adeno-associated virus/ bocavirus parvovirus vector
|
|
TWI679019B
(zh)
|
2013-04-29 |
2019-12-11 |
法商賽諾菲公司 |
抗ｉｌ－４／抗ｉｌ－１３之雙特異性抗體調配物
|
|
WO2014179771A1
(en)
|
2013-05-03 |
2014-11-06 |
Selecta Biosciences, Inc. |
Dosing combinations for reducing undesired humoral immune responses
|
|
BR112015027291A8
(pt)
|
2013-05-03 |
2019-12-24 |
Selecta Biosciences Inc |
uso de um imunossupressor que têm uma vida eficaz farmacodinâmica especificada e composição compreendendo o referido imunossupressor
|
|
IL295392A
(en)
|
2013-06-04 |
2022-10-01 |
Selecta Biosciences Inc |
Repeated administration of non-immunosupressive antigen specific immunotherapeutics
|
|
CA2926215A1
(en)
|
2013-10-06 |
2015-04-09 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Modified pseudomonas exotoxin a
|
|
US9276815B2
(en)
*
|
2013-12-27 |
2016-03-01 |
Dell Products L.P. |
N-node virtual link trunking (VLT) systems management plane
|
|
EP2916319A1
(en)
|
2014-03-07 |
2015-09-09 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Concept for encoding of information
|
|
JP6822841B2
(ja)
|
2014-03-09 |
2021-01-27 |
ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア |
オルニチントランスカルバミラーゼ（ｏｔｃ）欠損症の処置において有用な組成物
|
|
GB201407322D0
(en)
|
2014-04-25 |
2014-06-11 |
Ospedale San Raffaele |
Gene therapy
|
|
US20150358333A1
(en)
*
|
2014-06-04 |
2015-12-10 |
Grandios Technologies, Llc |
Geo-location and biometric presence security
|
|
US20150359865A1
(en)
|
2014-06-17 |
2015-12-17 |
Selecta Biosciences, Inc. |
Tolerogenic synthetic nanocarriers for t-cell-mediated autoimmune disease
|
|
US20160220501A1
(en)
|
2015-02-03 |
2016-08-04 |
Selecta Biosciences, Inc. |
Tolerogenic synthetic nanocarriers to reduce immune responses to therapeutic proteins
|
|
US20150374815A1
(en)
|
2014-06-25 |
2015-12-31 |
Selecta Biosciences, Inc. |
Methods and compositions for treatment with synthetic nanocarriers and immune checkpoint inhibitors
|
|
WO2016037164A1
(en)
|
2014-09-07 |
2016-03-10 |
Selecta Biosciences, Inc. |
Methods and compositions for attenuating gene expression modulating anti-viral transfer vector immune responses
|
|
WO2016055437A1
(en)
|
2014-10-06 |
2016-04-14 |
Arthrogen B.V. |
Aav-based gene therapy
|
|
FI3834823T3
(fi)
|
2014-11-05 |
2024-04-02 |
Cartesian Therapeutics Inc |
Menetelmiä ja koostumuksia liittyen alhaisen hlb:n omaavien pinta-aktiivisten aineiden käyttöön rapalogin käsittävien synteettisten nanokantajien valmistuksessa
|
|
EP3323832A4
(en)
|
2015-07-15 |
2018-12-26 |
Kyowa Hakko Kirin Co., Ltd. |
Antibody which specifically binds to human crth2
|
|
WO2017139212A1
(en)
|
2016-02-08 |
2017-08-17 |
Cyta Therapeutics, Inc. |
Particle delivery of rapamycin to the liver
|
|
WO2017138983A1
(en)
|
2016-02-10 |
2017-08-17 |
Pfizer Inc. |
Therapeutic nanoparticles having egfr ligands and methods of making and using same
|
|
IL318183A
(en)
|
2016-03-11 |
2025-03-01 |
Selecta Biosciences Inc |
Formulations and doses of pegylated uricase
|
|
GB201608323D0
(en)
|
2016-05-12 |
2016-06-29 |
Ucb Biopharma Sprl |
Pharmaceutical compositions
|
|
US10545815B2
(en)
|
2016-08-03 |
2020-01-28 |
Futurewei Technologies, Inc. |
System and method for data redistribution in a database
|
|
US20180071394A1
(en)
|
2016-08-25 |
2018-03-15 |
Selecta Biosciences, Inc. |
Polyester polymer matrices for the delivery of allergens
|
|
EP3518956A1
(en)
|
2016-09-27 |
2019-08-07 |
Selecta Biosciences, Inc. |
Recombinant immunotoxins for use in the treatment of cancer
|
|
US11583504B2
(en)
|
2016-11-08 |
2023-02-21 |
Modernatx, Inc. |
Stabilized formulations of lipid nanoparticles
|
|
WO2018093868A1
(en)
|
2016-11-16 |
2018-05-24 |
University Of Florida Research Foundation, Inc. |
Immunoglobulin proteases, compositions, and uses thereof
|
|
WO2018127382A1
(en)
|
2017-01-03 |
2018-07-12 |
Ethris Gmbh |
Ornithine transcarbamylase coding polyribonucleotides and formulations thereof
|
|
WO2018129268A1
(en)
|
2017-01-07 |
2018-07-12 |
Selecta Biosciences, Inc. |
Patterned dosing of immunosuppressants coupled to synthetic nanocarriers
|
|
KR102753928B1
(ko)
|
2017-03-11 |
2025-01-14 |
셀렉타 바이오사이언시즈, 인크. |
항염증제, 및 면역억제제를 포함하는 합성 나노담체를 사용한 조합 치료와 관련된 방법 및 조성물
|
|
MX2020003838A
(es)
|
2017-10-13 |
2020-08-06 |
Selecta Biosciences Inc |
Metodos y composiciones para atenuar las respuestas de inmunoglobulina m del vector de transferencia antiviral.
|
|
WO2019162951A1
(en)
|
2018-02-26 |
2019-08-29 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd |
Drug delivery systems
|
|
WO2019217552A1
(en)
|
2018-05-09 |
2019-11-14 |
Yale University |
Particles for spatiotemporal release of agents
|
|
JP2021531282A
(ja)
|
2018-07-16 |
2021-11-18 |
セレクタ バイオサイエンシーズ インコーポレーテッドSelecta Biosciences, Inc. |
Ｏｔｃコンストラクトおよびベクターの方法および組成物
|
|
EP3823676A1
(en)
|
2018-07-16 |
2021-05-26 |
Selecta Biosciences, Inc. |
Methods and compositions of mma constructs and vectors
|
|
BR112021021566A2
(pt)
|
2019-04-28 |
2022-04-19 |
Selecta Biosciences Inc |
Métodos para tratamento de indivíduos com imunidade preexistente a vetores de transferência viral
|
|
BR112021023594A2
(pt)
|
2019-05-28 |
2022-02-08 |
Selecta Biosciences Inc |
Métodos e composições para resposta imune de vetor de transferência antiviral atenuada
|
|
EP3980784A1
(en)
|
2019-06-04 |
2022-04-13 |
Selecta Biosciences, Inc. |
Formulations and doses of pegylated uricase
|
|
EP4048269A1
(en)
|
2019-10-21 |
2022-08-31 |
Selecta Biosciences, Inc. |
Methods and compositions for treating liver diseases and disorders
|
|
CN118384281A
(zh)
|
2019-11-08 |
2024-07-26 |
西莱克塔生物科技公司 |
聚乙二醇化尿酸酶的制剂和剂量
|
|
EP4110334A1
(en)
|
2020-02-26 |
2023-01-04 |
Selecta Biosciences, Inc. |
Methods and compositions using synthetic nanocarriers comprising immunosuppressant
|
|
AU2021236234A1
(en)
|
2020-03-11 |
2022-10-06 |
Selecta Biosciences, Inc. |
Methods and compositions related to synthetic nanocarriers
|
|
EP4215208A4
(en)
|
2020-09-21 |
2024-11-20 |
Shanghai Bao Pharmaceuticals Co., Ltd. |
PHARMACEUTICAL COMBINATION AND USE THEREOF
|
|
US20220133864A1
(en)
|
2020-11-04 |
2022-05-05 |
Selecta Biosciences, Inc. |
Methods and compositions for reducing immune responses against immunoglobulin proteases
|
|
AU2022206197A1
(en)
|
2021-01-05 |
2023-07-13 |
Selecta Biosciences, Inc. |
Viral vector dosing protocols
|
|
AU2022253064A1
(en)
|
2021-04-09 |
2023-10-19 |
Selecta Biosciences, Inc. |
Synthetic nanocarriers comprising an immunosuppressant in combination with high affinity il-2 receptor agonists to enhance immune tolerance
|
|
EP4079848A1
(en)
|
2021-04-22 |
2022-10-26 |
Genovis Ab |
Immunoglobulin cleaving enzyme
|
|
JP2024539646A
(ja)
|
2021-10-12 |
2024-10-29 |
カーティザン セラピューティクス，インコーポレーテッド |
ウイルスベクター投薬プロトコル
|
|
US20230141563A1
(en)
|
2021-10-12 |
2023-05-11 |
Selecta Biosciences, Inc. |
Methods and compositions for attenuating anti-viral transfer vector igm responses
|
|
US20230357437A1
(en)
|
2022-03-09 |
2023-11-09 |
Selecta Biosciences, Inc. |
Immunosuppressants in combination with anti-igm agents and related dosing
|
|
CA3264659A1
(en)
|
2022-08-11 |
2024-02-15 |
Cartesian Therapeutics, Inc. |
COMPOSITIONS AND PROCESSES ASSOCIATED WITH IMMUNOGLOBULIN PROTEASES AND FUSION THEREOF
|